The growing fears about Trump’s special ed plans

Trump’s plans for dismantling the Education Department are sparking concerns that the federal government will fall short in ...

4 risk treatment strategies that separate proactive businesses from reactive ones

Vanta reports four risk treatment strategies-mitigate, accept, transfer, and avoid-to effectively manage threats, enhancing ...
The Manila Times

Opus Genetics Announces FDA Alignment on Phase 3 Registrational Trial Design for OPGx-LCA5 in LCA5-Associated Inherited Retinal Disease

Opus Genetics, Inc. (Nasdaq: IRD) (the "Company” or "Opus Genetics”), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients with ...
University of California, San Francisco

New Program at UCSF and UC Berkeley Will Drive Advances in Medicine

UCSF and UC Berkeley have launched a joint program to develop the frontier of AI in biomedicine and accelerate advances in ...